This study is in progress, not accepting new patients

Music, Social Attention, and Dementia

a study on Dementia Frontotemporal Dementia Alzheimer's Disease Behavioral Variant Frontotemporal Dementia Caregivers

Summary

Eligibility
for people ages 55-89 (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California
Dates
study started
study ends around
Principal Investigator
by Aaron Colverson, PhD
Headshot of Aaron Colverson
Aaron Colverson

Description

Summary

This is an exploratory mixed-methods control-treatment study to evaluate if participation in rhythmic musical activities improves social attention and connectedness in individuals living with mild to moderate bvFTD and AD, and their caregivers. Secondary objectives include evaluating the potential relationships between brain networks associated with rhythm production, social attention, and connectedness in these populations.

Official Title

The Impact of a Caregiver-patient Music Intervention on Social Attention and Connectedness in Persons Living With bvFTD and AD

Details

The proposed research will evaluate potential relationships between synchronous rhythm production, social attention, and connectedness in persons living with mild to moderate bvFTD and AD and their caregivers. To evaluate these relationships, the proposed research will include data collection and analysis of the following: 1) pre-post evaluation of social attention and connectedness in individuals living with dementia and their caregivers; 2) control-treatment participation in a synchronous (treatment) or solo (control) rhythm production activity; and 3) secondary analysis of structural and functional MRI of resting state network connectivity between networks of the brain including areas associated with rhythm perception and production, namely the fronto-parietal, executive control, sensorimotor, dorsal and ventral attention networks.

Keywords

Frontotemporal Dementia, Alzheimer Disease, Synchronous Rhythm Production, Solo Rhythm Production

Eligibility

For people ages 55-89

Inclusion (patients)

  • Male or female ≥ 55 years of age living with bvFTD; or ≥ 70 years of age living with AD.
  • Documentation of a bvFTD or AD diagnosis as evidenced by one or more known clinical features.
  • Written informed consent obtained from subject.

Inclusion (caregivers)

  • Male or female ≥ 55 years of age living without diagnosis of neurological or psychiatric disease.
  • Individual capable of independent execution of activities of daily living, including personal care and hygiene, dressing, eating, use of a toilet, and mobility.
  • Written informed consent.

Exclusion (patients)

  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
  • community-dwelling individuals not living with bvFTD
  • Individuals with a score of 2 or higher on the CDR
  • Individuals with a history of neuropsychiatric illness that would interfere with performance (e.g., transient psych hx of depression okay, hx of schizophrenia will be excluded) or medicated depression to control symptoms.
  • Individuals with unstable (e.g., cancer other than basal cell skin) or chronic (e.g., severe diabetes) medical conditions
  • Individuals with MRI contraindications (e.g., pregnancy, claustrophobia, metal implants that are contraindicated for MRI)
  • Individuals with physical impairment(s) precluding motor response
  • Individuals with inability to walk two blocks without stopping
  • Individuals with hearing or vision deficits that will not allow for completion of testing; inability to hear conversation conducted at an average volume (~60 dB)
  • Individuals who practice music making or production for at least 30-mins per week
    • This may include instrumental or vocal, writing or arranging, alone or in groups
    • Listening to music for more than 30-mins weekly will not exclude the individual from the study

Exclusion (Caregivers)

  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.

  • Community-dwelling individuals living with diagnosis of a neurological or psychiatric disease

    o Community-dwelling individuals with abnormal cognitive functioning

  • Individuals living with dementia
  • Individuals with a history of neuropsychiatric illness that would interfere with performance (e.g., transient psych hx of depression okay, hx of schizophrenia will be excluded) or medicated depression to control symptoms
  • Individuals with unstable (e.g., cancer other than basal cell carcinoma) or chronic (e.g., severe diabetes) medical conditions
  • Individuals with physical impairment(s) precluding motor control
  • Individuals with inability to walk two blocks without stopping
  • Individuals with hearing or vision deficits that will not allow for completion of testing; inability to hear conversation conducted at an average volume (~60 dB)
  • Individuals who practice music making or production for at least 30-mins per week
    • This may include instrumental or vocal, writing or arranging, alone or in groups
    • Listening to music for more than 30-mins weekly will not exclude the individual from the study

Location

  • Sandler Neurosciences Center
    San Francisco California 94158 United States

Lead Scientist at UCSF

  • Aaron Colverson, PhD
    Aaron studies rhythm perception, learning, and performance in aging using a mixed-methods approach involving neuropsychological assessment, a rhythmic musical activity, and functional magnetic resonance imaging. His postdoctoral work includes training in brain imaging and statistical methods.

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06768996
Study Type
Interventional
Participants
About 80 people participating
Last Updated